Ibsrela vs. Motegrity
Are Ibsrela and Motegrity the Same Thing?
Ibsrela (tenapanor) and Motegrity (prucalopride) are used to treat irritable bowel syndrome with constipation (IBS-C) in adults.
Ibsrela and Motegrity belong to different drug classes. Ibsrela is a sodium/hydrogen exchanger 3 (NHE3) inhibitor and Motegrity is a serotonin-4 (5-HT4) receptor agonist.
Side effects of Ibsrela and Motegrity that are similar include diarrhea, abdominal distension bloating, gas (flatulence), and dizziness.
Side effects of Motegrity that are different from Ibsrela include headache, abdominal pain, nausea, vomiting, and fatigue.
Ibsrela may interact with other drugs.
Motegrity may also interact with erythromycin or ketoconazole.
What Are Possible Side Effects of Ibsrela?
Common side effects of Ibsrela include:
- diarrhea,
- abdominal distension,
- gas (flatulence), and
- dizziness.
What Are Possible Side Effects of Motegrity?
Common side effects of Motegrity include:
- headache,
- abdominal pain,
- nausea,
- diarrhea,
- bloating,
- dizziness,
- vomiting,
- gas (flatulence), and
- fatigue
What Is Ibsrela?
Ibsrela (tenapanor) is a sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
What Is Motegrity?
Motegrity (prucalopride) is a serotonin-4 (5-HT4) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
What Drugs Interact With Ibsrela?
Ibsrela may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Ibsrela; maternal use is not expected to result in fetal exposure to the drug. It is unknown if Ibsrela passes into breast milk. Consult your doctor before breastfeeding.
What Drugs Interact With Motegrity?
Motegrity may interact with erythromycin or ketoconazole. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Motegrity; it is unknown how it would affect a fetus. Motegrity passes into breast milk. Consult your doctor before breastfeeding.
How Should Ibsrela Be Taken?
The recommended dosage of Ibsrela in adults is 50 mg, orally twice daily.
How Should Motegrity Be Taken?
The recommended dose of Motegrity is 2 mg once daily.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.